Contact us

China National Pharmaceutical
Group Corporation(SINOPHARM)
Address: No.20 Zhichun
Road, Haidian District, Beijing, China
Postal Code: 100191
Fax: 86-10-62033332


Learn more >>

Sinopharm News

A New Generation of ORS Drug With Great Market Potential Is Approved To Launch In Chinese Market -1

Post Time:2009-06-09 [Large Middle Small] View:
Oral Rehydration Salts,(ORS) has been recommended for the treatment of mild to moderate dehydration due to acute diarrhea by the World Health Organization (WHO) since 1970s. ORS is evaluated as the 20th century's greatest medical advances By the Lancet, a medical magazine with global authority, as it has ORS has been widely used for more than twenty years and greatly reduced the fatality rate of acute diarrhea.
WHO officially recommended the use of a new generation of ORS rehydration salts Ⅲ(brand name: Bo Ye) to replace the original ORS on March 23, 2006. This new formula will supply a better treatment for acute diarrhea disease.
Xi’an Anjian Pharmaceutical Co., Ltd. started the special R&D on ORS and drug for the treatment of diarrhea in 2002, and a new drug -- oral rehydration saltⅢ, domestic exclusive product obtained the approval for marketing issued by SFDA on April 14, 2009, which opens a new chapter in the domestic field of treatment of diarrhea diseases.
Diarrhea diseases and oral rehydration therapy
Diarrhea diseases is a common comprehensive digestive tract disease,  acute diarrhea often leads to dehydration and electrolyte disorders, and persistent diarrhea causes malnutrition, a serious threat to human health. At present, diarrhea is the second main reason of death in children as there are millions of children die from dehydration due to diarrhea every year.
The majority of doctors choose antibiotics with intravenous administration to treat diarrhea disease for a long time.
XML 地图 | Sitemap 地图